IVD Medical Acquires $19M in Ether to Fuel Tokenization Platform and On-Chain Treasury
Hong Kong-based IVD Medical Holdings has purchased $19 million worth of ether (ETH), integrating the asset as the foundation of its upcoming Ethereum-powered tokenization platform, ivd.xyz.
The platform will focus on tokenizing pharmaceutical IP and healthcare assets, leveraging Ethereum smart contracts for ownership tracking, automated revenue distribution, and compliance governance. IVD’s ETH holdings will also back its planned IVDD stablecoin, aimed at facilitating cross-border settlements within Hong Kong and U.S. regulatory frameworks.
Chief Strategy Officer Gary Deng told CoinDesk the firm chose Ethereum due to its “maturity, liquidity, and growing institutional credibility,” citing the SEC’s recent spot ETH ETF approval.
Beyond passive holding, IVD plans to stake and re-stake its ETH while exploring on-chain derivatives to optimize yield and protect against downside risk. Revenue from tokenized asset transactions will be auto-converted into ETH and held in the treasury.
This move places IVD among a small group of HKEX-listed companies integrating crypto into their balance sheets. Others include Boyaa Interactive, with over 3,100 BTC, and Meitu, which previously held 31,000 ETH and 940 BTC.
The announcement coincides with IVD’s broader partnership with HashKey Group, operator of the licensed HashKey exchange in Hong Kong.
